Combined inhibition of BTK and PI3K acts synergistically in a canine B-cell lymphoma in vitro model

Kong W, Sender S, Sekora A, Ma Y, Ruetgen B, Nolte I, Taher L, Brenig B, Beck J, Schuetz E, Junghanss C, Escobar MH (2019)

Publication Type: Conference contribution

Publication year: 2019

Journal

Oncology Research and Treatment Karger Publishers

Publisher: KARGER

City/Town: BASEL

Pages Range: 119-119

Conference Proceedings Title: ONCOLOGY RESEARCH AND TREATMENT

Authors with CRIS profile

Leila Taher Juniorprofessur für Bioinformatik

Involved external institutions

Universität Rostock DE Germany (DE) Stiftung Tierärztliche Hochschule Hannover (TiHo) DE Germany (DE) Georg-August-Universität Göttingen DE Germany (DE) Chronix Biomedical GmbH DE Germany (DE)

How to cite

APA:

Kong, W., Sender, S., Sekora, A., Ma, Y., Ruetgen, B., Nolte, I.,... Escobar, M.H. (2019). Combined inhibition of BTK and PI3K acts synergistically in a canine B-cell lymphoma in vitro model. In ONCOLOGY RESEARCH AND TREATMENT (pp. 119-119). BASEL: KARGER.

MLA:

Kong, W., et al. "Combined inhibition of BTK and PI3K acts synergistically in a canine B-cell lymphoma in vitro model." Proceedings of the ONCOLOGY RESEARCH AND TREATMENT BASEL: KARGER, 2019. 119-119.

BibTeX: Download